slides · global inventory
Monroes Sequence
Arc collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 33,236
Current window 18,391-18,420
Pages 1,108
Rows per page 30
Arc
18,391-18,420 of 33,236
07
Includes a boxed warning disclaimer at the bottom.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
08
The chart shows a steady upward trend in total prescriptions (TRx) over 61 weeks, with a notable dip around week 58.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
09
Alkermes | Investor Presentation Deck | 28 slidesAlkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
10
The slide uses a combination of a treatment matrix and a donut chart to align product labeling with real-world patient needs.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
11
The slide includes a disclaimer regarding the boxed warning for the drug.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
12
Alkermes | Investor Presentation Deck | 28 slidesAlkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
13
Alkermes | Investor Presentation Deck | 28 slidesAlkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · ActionLoop · Why Now1 hit
14
The slide uses a medical illustration of the brain to show neurotransmitter pathways.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · ActionLoop · Why Now1 hit
15
Includes a molecular structure visualization of the Orexin 2 receptor.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · ActionLoop · Why Now1 hit
16
The slide presents preclinical efficacy data for RDC-264177 using a DTA mouse model.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · ActionLoop · Why Now1 hit
17
The slide uses PharmacoEEG heatmaps to visualize brain activity frequency over time.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · ActionLoop · Why Now1 hit
18
The slide uses a process flow diagram to illustrate the progression from Single Ascending Dose to Multiple Ascending Dose and Proof-of-Concept studies.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · ActionLoop · Why Now1 hit
19
The slide uses a side-by-side comparison layout to delineate two distinct clinical trial phases.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · ActionLoop · Why Now1 hit
20
Alkermes | Investor Presentation Deck | 28 slidesAlkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · Action1 hit
21
The slide outlines the core assets (nemvaleukin alfa, IL-12, IL-18) and the strategic rationale for a spin-off.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · Action1 hit
22
The slide uses a human body diagram to map clinical responses (CR, PR, uPR) by tumor type.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · Action1 hit
23
The slide uses a 2x2 matrix-like layout to categorize studies by 'Potential Registration Enabling Studies' and 'Alternative Dosing Studies'.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · Action1 hit
24
Alkermes | Investor Presentation Deck | 28 slidesAlkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · Action1 hit
25
The slide outlines the strategic rationale for a corporate spin-off, focusing on the remaining neuroscience-focused entity.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · Action1 hit
26
The chart tracks revenue for VIVITROL, ARISTADA, VUMERITY, and LYBALVI.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · Action1 hit
27
Alkermes | Investor Presentation Deck | 28 slidesAlkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · Action1 hit
28
Alkermes | Investor Presentation Deck | 28 slidesAlkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · Action1 hit
01
Includes Exhibit 99.1 designation, indicating this is a regulatory filing.First Republic Bank | Results Presentation Deck | 50 slides · First Republic Bank
Regulatory filing Investor relations Beat · Attention1 hit
02
Includes non-GAAP financial measure disclosures.First Republic Bank | Results Presentation Deck | 50 slides · First Republic Bank
Regulatory filing Investor relations Beat · Attention1 hit
03
The slide uses a circular 2x2 matrix layout to categorize strategic strengths.First Republic Bank | Results Presentation Deck | 50 slides · First Republic Bank
Regulatory filing Investor relations Beat · NeedLoop · Logic Chain1 hit
04
The diagram is a hub-and-spoke model centered on the client, surrounded by service offerings and communication channels.First Republic Bank | Results Presentation Deck | 50 slides · First Republic Bank
Regulatory filing Investor relations Beat · NeedLoop · Logic Chain1 hit
05
The slide highlights a 62% concentration of HNW households in FRC's urban coastal markets, up from 46% in 2003.First Republic Bank | Results Presentation Deck | 50 slides · First Republic Bank
Regulatory filing Investor relations Beat · NeedLoop · Logic Chain1 hit
06
The slide highlights First Republic's superior NPS compared to industry peers and the banking sector, attributing this to organic growth through referrals.First Republic Bank | Results Presentation Deck | 50 slides · First Republic Bank
Regulatory filing Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
07
The slide uses a stacked bar chart to demonstrate the 'flywheel' effect of client satisfaction leading to organic growth.First Republic Bank | Results Presentation Deck | 50 slides · First Republic Bank
Regulatory filing Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
08
First Republic Bank | Results Presentation Deck | 50 slidesFirst Republic Bank | Results Presentation Deck | 50 slides · First Republic Bank
Regulatory filing Investor relations Beat · SatisfactionLoop · Logic Chain1 hit